Compare LUNR & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUNR | PAHC |
|---|---|---|
| Founded | 2013 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | N/A | 2014 |
| Metric | LUNR | PAHC |
|---|---|---|
| Price | $21.52 | $41.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | $17.40 | ★ $31.25 |
| AVG Volume (30 Days) | ★ 15.1M | 244.0K |
| Earning Date | 11-13-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 1.17% |
| EPS Growth | N/A | ★ 288.74 |
| EPS | N/A | ★ 1.67 |
| Revenue | $219,936,000.00 | ★ $1,399,676,000.00 |
| Revenue This Year | N/A | $15.34 |
| Revenue Next Year | $143.74 | $3.28 |
| P/E Ratio | ★ N/A | $24.58 |
| Revenue Growth | 7.85 | ★ 33.72 |
| 52 Week Low | $6.14 | $16.16 |
| 52 Week High | $24.95 | $46.42 |
| Indicator | LUNR | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 70.73 | 58.72 |
| Support Level | $17.16 | $39.27 |
| Resistance Level | $20.02 | $41.27 |
| Average True Range (ATR) | 1.74 | 1.40 |
| MACD | 0.15 | 0.37 |
| Stochastic Oscillator | 87.74 | 89.08 |
Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure. The Company operates in one operating segment and one reportable segment underpinned by three core pillars (delivery services, data transmission services, and infrastructure as a service) that have similar capabilities, customers, and economic characteristics. Revenue is from contracts with customers of orbital and lunar access services.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.